https://www.targetedonc.com/view/molecular-subtyping-leads-to-new-targeted-trials-in-endometrial-cancer
Ruchi Garg, MD, discusses the impact of targeted therapies studies in patients with early and recurrent endometrial cancer.
Create an account or login to join the discussion